“`html

In a significant move, the Securities and Exchange Commission’s (SEC) Division of Examinations has unveiled its 2025 examination priorities, setting the stage for what could be a transformative year in financial regulation. The release, dated October 21, 2024, aims to guide registered investment advisers, investment companies, and broker-dealers on the areas of focus during upcoming examinations.


The 2025 priorities come amidst a changing presidential administration, which could lead to shifts in SEC focus. However, many of the priorities are expected to persist, emphasizing the need for firms to carefully review these priorities and consult with legal counsel as needed.


Investment Advisers

The SEC’s Division will continue to prioritize examinations of investment advisers, particularly those who have never been examined or have not been examined recently. Key areas of focus will include fiduciary standards, compliance programs, and private fund advisers.


Fiduciary Duties

Investment advisers must adhere to fiduciary standards of conduct, acting in the best interests of their clients and disclosing any conflicts of interest. The Division will scrutinize investment advice related to high-cost products, unconventional instruments, and assets sensitive to market changes.


Compliance Programs

Compliance with Rule 206(4)-7 under the Investment Advisers Act of 1940 remains a priority. Examinations will evaluate core compliance areas such as marketing, valuation, and trading. Special attention will be given to advisers integrating AI into their operations.


Private Fund Advisers

Private fund advisers will also be under the spotlight, especially those using investment strategies sensitive to market volatility and interest rate changes. The Division will examine conflicts of interest disclosures and compliance with new regulatory amendments.


Broker-Dealers

For broker-dealers, Regulation Best Interest (Reg BI) and Form CRS obligations remain top priorities. The Division will assess whether broker-dealers are making recommendations in the best interests of their clients and properly disclosing conflicts of interest.


Regulation Best Interest

Broker-dealers must ensure that their recommendations are in the best interests of their clients. Examinations will focus on complex and high-risk products, including crypto assets and structured products.


Form CRS

The SEC requires broker-dealers to provide Form CRS to retail investors, detailing their relationships, services, and fees. The Division will review the content of these summaries to ensure transparency and compliance.


Risk Areas

Several key risk areas have been highlighted, including cybersecurity, compliance with recent amendments, financial technologies, and crypto assets. The Division will ensure that practices prevent service interruptions and protect investor information.


Cybersecurity

Examinations will focus on policies and procedures to prevent data breaches and protect client information, with special attention to the use of third-party products and services.


Financial Technologies

With AI on the rise, the Division will review the use of automated investment tools and ensure that firms monitor and supervise AI use effectively.


Crypto Assets

Crypto assets remain a top priority, with examinations reviewing compliance practices and risk disclosures related to crypto securities.


For a more detailed exploration of these priorities, the original article by Eric Mikkelson and Carissa Occhipinto can be found on Stinson LLP’s website. This comprehensive guide underscores the SEC’s commitment to safeguarding investors and ensuring market integrity.

“`

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Gene Editing: A Promising Frontier in Biotechnology

Gene editing technology is swiftly emerging as a transformative force in both healthcare and agriculture, particularly through tools like CRISPR-Cas9, which offer precise methods to modify genes and promise to revolutionize treatment for genetic disorders, cancer, and infectious diseases.

Empowering the Gig Economy: AXA’s Tailored Protection

Angela Wong, Chief Marketing and Customer Officer at AXA Hong Kong & Macau, underscores the critical need for comprehensive insurance solutions for gig workers.

By |November 24, 2024|Categories: Article, Business, Insurance|Tags: , |0 Comments

Ethical Deployment of AI in Healthcare: AMA’s Guiding Strategies

The AMA highlights that AI's integration must be guided by the fundamental principles of medical ethics: patient autonomy, beneficence, nonmaleficence, and justice.

By |November 24, 2024|Categories: Article, Healthcare, Technology Ethics|Tags: , |0 Comments

AI’s Role in Revolutionizing Medical Education

AI, which simulates human intelligence, is reshaping various sectors, particularly healthcare. The ability to perform complex tasks, such as diagnostics and personalized healthcare, is no longer confined to human capabilities alone.

By |November 23, 2024|Categories: Article, Education, Technology|Tags: , |0 Comments

AI Chatbots in Chronic Disease Diagnosis

A recent study published in Nature on July 25, 2024, unveils a cutting-edge chatbot named Chat Ella, designed to assist in the diagnosis of chronic diseases.

Revolutionizing Genetic Research with CRISPR-Cas Technology

CRISPR-Cas technology is not just a tool but a gateway to understanding the genetic influences on diseases.